Disulfide-containing parenteral delivery systems and their redox-biological fate

Journal of Controlled Release

Volumn 195, Issue , 2014, Pages 147-154

  Brülisauer, Lorine ^a   Gauthier, Marc A ^b   Leroux, Jean Christophe ^a  

^a ETH ZURICH   (Switzerland)

^b INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE   (Canada)

Author keywords

Cancer; Delivery system; Disulfide; Parenteral; Redox potential; Thiol disulfide exchange

Indexed keywords

BIODEGRADATION; CONTROLLED DRUG DELIVERY; COVALENT BONDS; DISEASES; NUCLEIC ACIDS; REDOX REACTIONS; REDUCING AGENTS; SULFUR COMPOUNDS;

CANCER; DELIVERY SYSTEMS; DISULFIDE; PARENTERAL; REDOX POTENTIALS; THIOL DISULFIDE EXCHANGE;

TARGETED DRUG DELIVERY;

ANTIBODY CONJUGATE; CELL PENETRATING PEPTIDE; DISULFIDE; DRUG CARRIER; FOLIC ACID; LIPOPLEX; LIPOSOME; NANOPARTICLE; NUCLEIC ACID; OXIDOREDUCTASE; TRANSFERRIN;

ARTICLE; BLOOD VESSEL; CARDIOVASCULAR SYSTEM; CELL POPULATION; CIRCULATION; COMPLEX FORMATION; CYTOPLASM; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENDOTHELIUM CELL; EX VIVO STUDY; GEL ELECTROPHORESIS; INTERSTITIUM; OXIDATION REDUCTION POTENTIAL; PARENTERAL DRUG ADMINISTRATION; PLASMA; PROFESSIONAL KNOWLEDGE; ANIMAL; ENDOSOME; HUMAN; METABOLISM; NEOPLASM; OXIDATION REDUCTION REACTION;

ANIMALS; BLOOD VESSELS; CYTOPLASM; DISULFIDES; DRUG DELIVERY SYSTEMS; ENDOSOMES; ENDOTHELIAL CELLS; HUMANS; NEOPLASMS; OXIDATION-REDUCTION;

EID: 84908606333     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.06.012     Document Type: Review

References (106)

1. S.F. Betz Disulfide bonds and the stability of globular proteins Protein Sci. 2 1993 1551 1558
2. C.S. Sevier, and C.A. Kaiser Formation and transfer of disulphide bonds in living cells Nat. Rev. Mol. Cell Biol. 3 2002 836 847
3. P.J. Hogg Disulfide bonds as switches for protein function Trends Biochem. Sci. 28 2003 210 214
4. P. Palumaa Biological redox switches Antioxid. Redox Signal. 11 2009 981 983
5. M.A. Wouters, S.W. Fan, and N.L. Haworth Disulfides as redox switches: from molecular mechanisms to functional significance Antioxid. Redox Signal. 12 2010 53 91
6. Y.-M. Go, and D.P. Jones Redox compartmentalization in eukaryotic cells Biochim. Biophys. Acta, Gen. Subj 1780 2008 1273 1290
7. P. Ghezzi, V. Bonetto, and M. Fratelli Thiol-disulfide balance: from the concept of oxidative stress to that of redox regulation Antioxid. Redox Signal. 7 2005 964 972
8. M. Kemp, Y.-M. Go, and D.P. Jones Nonequilibrium thermodynamics of thiol/disulfide redox systems: a perspective on redox systems biology Free Radic. Biol. Med. 44 2008 921 937
9. S.E. Moriarty-Craige, and D.P. Jones Extracellular thiols and thiol/disulfide redox in metabolism Annu. Rev. Nutr. 24 2004 481 509
10. S.C. Alley, N.M. Okeley, and P.D. Senter Antibody-drug conjugates: targeted drug delivery for cancer Curr. Opin. Chem. Biol. 14 2010 529 537
11. P.D. Senter Potent antibody drug conjugates for cancer therapy Curr. Opin. Chem. Biol. 13 2009 235 244
12. F. Kratz, I.A. Müller, C. Ryppa, and A. Warnecke Prodrug strategies in anticancer chemotherapy ChemMedChem 3 2008 20 53
13. G. Saito, J.A. Swanson, and K.-D. Lee Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities Adv. Drug Deliv. Rev. 55 2003 199 215
14. A.M. Wu, and P.D. Senter Arming antibodies: prospects and challenges for immunoconjugates Nat. Biotechnol. 23 2005 1137 1146
15. R.V.J. Chari, M.L. Miller, and W.C. Widdison Antibody-drug conjugates: an emerging concept in cancer therapy Angew. Chem. Int. Ed. 53 2014 3796 3827
16. L. Ducry, and B. Stump Antibody-drug conjugates: linking cytotoxic payloads to monoclonal antibodies Bioconjug. Chem. 21 2009 5 13
17. N.K. Damle, and P. Frost Antibody-targeted chemotherapy with immunoconjugates of calicheamicin Curr. Opin. Pharmacol. 3 2003 386 390
18. S. Bauhuber, C. Hozsa, M. Breunig, and A. Göpferich Delivery of nucleic acids via disulfide-based carrier systems Adv. Mater. 21 2009 3286 3306
19. C. Lin, and J.F. Engbersen The role of the disulfide group in disulfide-based polymeric gene carriers Expert Opin. Drug Deliv. 6 2009 421 439
20. P.M. Klein, and E. Wagner Bioreducible polycations as shuttles for therapeutic nucleic acid and protein transfection Antioxid. Redox Signal. 2013 10.1089/ars.2013.5714
21. F. Meng, W.E. Hennink, and Z. Zhong Reduction-sensitive polymers and bioconjugates for biomedical applications Biomaterials 30 2009 2180 2198
22. R. Cheng, F. Feng, F. Meng, C. Deng, J. Feijen, and Z. Zhong Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery J. Control. Release 152 2011 2 12
23. H. Sun, F. Meng, R. Cheng, C. Deng, and Z. Zhong Reduction-sensitive degradable micellar nanoparticles as smart and intuitive delivery systems for cancer chemotherapy Expert Opin. Drug Deliv. 10 2013 1109 1122
24. M.A. Gauthier Redox-responsive drug delivery Antioxid. Redox Signal. 2014 10.1089/ars.2014.5980
25. H.F. Gilbert Thiol/disulfide exchange equilibria and disulfide bond stability L. Packer, Methods in Enzymology 251 1995 Academic Press 8 28
26. K.S. Jensen, R.E. Hansen, and J.R. Winther Kinetic and thermodynamic aspects of cellular thiol-disulfide redox regulation Antioxid. Redox Signal. 11 2009 1047 1058
27. P. Nagy Kinetics and mechanisms of thiol-disulfide exchange covering direct substitution and thiol oxidation-mediated pathways Antioxid. Redox Signal. 18 2013 1623 1641
28. L. Turell, R. Radi, and B. Alvarez The thiol pool in human plasma: the central contribution of albumin to redox processes Free Radic. Biol. Med. 65 2013 244 253
29. D.C. Sullivan, L. Huminiecki, J.W. Moore, J.J. Boyle, R. Poulsom, D. Creamer, J. Barker, and R. Bicknell EndoPDI, a novel protein-disulfide isomerase-like protein that is preferentially expressed in endothelial cells acts as a stress survival factor J. Biol. Chem. 278 2003 47079 47088
30. X.-M. Jiang, M. Fitzgerald, C.M. Grant, and P.J. Hogg Redox control of exofacial protein thiols/disulfides by protein disulfide isomerase J. Biol. Chem. 274 1999 2416 2423
31. P.E. Thorpe, P.M. Wallace, P.P. Knowles, M.G. Relf, A.N.F. Brown, G.J. Watson, R.E. Knyba, E.J. Wawrzynczak, and D.C. Blakey New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo Cancer Res. 47 1987 5924 5931
32. N.L. Letvin, V.S. Goldmacher, J. Ritz, J.M. Yetz, S.F. Schlossman, and J.M. Lambert In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. In vivo stability of disulfide-linked immunotoxin conjugates J. Clin. Invest. 77 1986 977 984
33. S. Ramakrishnan, and L.L. Houston Immunological and biological stability of immunotoxins in vivo as studied by the clearance of disulfide-linked pokeweed antiviral protein-antibody conjugates from blood Cancer Res. 45 1985 2031 2036
34. L. Greenfield, W. Bloch, and M. Moreland Thiol-containing cross-linking agent with enhanced steric hindrance Bioconjug. Chem. 7 1990 400 410
35. S. Arpicco, F. Dosio, P. Brusa, P. Crosasso, and L. Cattel New coupling reagents for the preparation of disulfide cross-linked conjugates with increased stability Bioconjug. Chem. 8 1997 327 337
36. S.F. Carroll, S.L. Bernhard, D.A. Goff, R.J. Bauer, W. Leach, and A.H.C. Kung Enhanced stability in vitro and in vivo of immunoconjugates prepared with 5-methyl-2-iminothiolane Bioconjug. Chem. 5 1994 248 256
37. B.A. Kellogg, L. Garrett, Y. Kovtun, K.C. Lai, B. Leece, M. Miller, G. Payne, R. Steeves, K.R. Whiteman, W. Widdison, H. Xie, R. Singh, R.V.J. Chari, J.M. Lambert, and R.J. Lutz Disulfide-linked antibody-maytansinoid conjugates: optimization of in vivo activity by varying the steric hindrance at carbon atoms adjacent to the disulfide linkage Bioconjug. Chem. 22 2011 717 727
38. C.D. Austin, X. Wen, L. Gazzard, C. Nelson, R.H. Scheller, and S.J. Scales Oxidizing potential of endosomes and lysosomes limits intracellular cleavage of disulfide-based antibody-drug conjugates Proc. Natl. Acad. Sci. U. S. A. 102 2005 17987 17992
39. J. Yang, H. Chen, I.R. Vlahov, J.-X. Cheng, and P.S. Low Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imaging Proc. Natl. Acad. Sci. U. S. A. 103 2006 13872 13877
40. D. Collins, E. Unanue, and C. Harding Reduction of disulfide bonds within lysosomes is a key step in antigen processing J. Immunol. 147 1991 4054 4059
41. C. Wu, S. Wang, L. Brülisauer, J.-C. Leroux, and M.A. Gauthier Broad control of disulfide stability through microenvironmental effects and analysis in complex redox environments Biomacromolecules 14 2013 2383 2388
42. S. Aubry, F. Burlina, E. Dupont, D. Delaroche, A. Joliot, S. Lavielle, G. Chassaing, and S. Sagan Cell-surface thiols affect cell entry of disulfide-conjugated peptides FASEB J. 23 2009 2956 2967
43. Y.-J. Lee, S. Datta, and J.-P. Pellois Real-time fluorescence detection of protein transduction into live cells J. Am. Chem. Soc. 130 2008 2398 2399
44. M. Neu, O. Germershaus, S. Mao, K.-H. Voigt, M. Behe, and T. Kissel Crosslinked nanocarriers based upon poly(ethylene imine) for systemic plasmid delivery: in vitro characterization and in vivo studies in mice J. Control. Release 118 2007 370 380
45. D. Oupickyacutea, R.C. Carlisle, and L.W. Seymour Triggered intracellular activation of disulfide crosslinked polyelectrolyte gene delivery complexes with extended systemic circulation in vivo Gene Ther. 8 2001 713 724
46. Q.-H. Zhou, D.L. Miller, R.C. Carlisle, L.W. Seymour, and D. Oupicky Ultrasound-enhanced transfection activity of HPMA-stabilized DNA polyplexes with prolonged plasma circulation J. Control. Release 106 2005 416 427
47. L. Brülisauer, N. Kathriner, M. Prenrecaj, M.A. Gauthier, and J.-C. Leroux Tracking the bioreduction of disulfide-containing cationic dendrimers Angew. Chem. Int. Ed. 51 2012 12454 12458
48. W. Sun, and P.B. Davis Reducible DNA nanoparticles enhance in vitro gene transfer via an extracellular mechanism J. Control. Release 146 2010 118 127
49. S. Takae, K. Miyata, M. Oba, T. Ishii, N. Nishiyama, K. Itaka, Y. Yamasaki, H. Koyama, and K. Kataoka PEG-detachable polyplex micelles based on disulfide-linked block catiomers as bioresponsive nonviral gene vectors J. Am. Chem. Soc 130 2008 6001 6009
50. D. Pezzoli, M. Zanda, R. Chiesa, and G. Candiani The yin of exofacial protein sulfhydryls and the yang of intracellular glutathione in in vitro transfection with SS14 bioreducible lipoplexes J. Control. Release 165 2013 44 53
51. 4-PDLLA micelles for chemotherapy Biomaterials 34 2013 552 561
52. Y. Li, K. Xiao, J. Luo, W. Xiao, J.S. Lee, A.M. Gonik, J. Kato, T.A. Dong, and K.S. Lam Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery Biomaterials 32 2011 6633 6645
53. T. Ishida, M.J. Kirchmeier, E.H. Moase, S. Zalipsky, and T.M. Allen Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells Biochim. Biophys. Acta Biomembr. 1515 2001 144 158
54. J.X. Zhang, S. Zalipsky, N. Mullah, M. Pechar, and T.M. Allen Pharmaco attributes of dioleoylphosphatidylethanolamine/cholesterylhemisuccinate liposomes containing different types of cleavable lipopolymers Pharmacol. Res. 49 2004 185 198
55. Y. Yan, Y. Wang, J.K. Heath, E.C. Nice, and F. Caruso Cellular association and cargo release of redox-responsive polymer capsules mediated by exofacial thiols Adv. Mater. 23 2011 3916 3921
56. A.M. Sauer, A. Schlossbauer, N. Ruthardt, V. Cauda, T. Bein, and C. Bräuchle Role of endosomal escape for disulfide-based drug delivery from colloidal mesoporous silica evaluated by live-cell imaging Nano Lett. 10 2010 3684 3691
57. D. Giustarini, A. Milzani, I. Dalle-Donne, and R. Rossi Red blood cells as a physiological source of glutathione for extracellular fluids Blood Cells Mol. Dis. 40 2008 174 179
58. D. Giustarini, I. Dalle-Donne, S. Lorenzini, A. Milzani, and R. Rossi Age-related influence on thiol, disulfide, and protein-mixed disulfide levels in human plasma Gerontol. Ser. A 61 2006 1030 1038
59. L. Turell, H. Botti, S. Carballal, R. Radi, and B. Alvarez Sulfenic acid - a key intermediate in albumin thiol oxidation J. Chromatogr. B 877 2009 3384 3392
60. S. Sugio, A. Kashima, S. Mochizuki, M. Noda, and K. Kobayashi Crystal structure of human serum albumin at 2.5 Å resolution Protein Eng. 12 1999 439 446
61. A.J. Stewart, C.A. Blindauer, S. Berezenko, D. Sleep, D. Tooth, and P.J. Sadler Role of Tyr84 in controlling the reactivity of Cys34 of human albumin FEBS J. 272 2005 353 362
62. B. Wilkinson, and H.F. Gilbert Protein disulfide isomerase Biochim. Biophys. Acta Protein Proteomics 1699 2004 35 44
63. K.A. Hotchkiss, L.J. Matthias, and P.J. Hogg Exposure of the cryptic Arg-Gly-Asp sequence in thrombospondin-1 by protein disulfide isomerase Biochim. Biophys. Acta Protein Struct. Mol. Enzymol. 1388 1998 478 488
64. D.P. Jones, V.C. Mody Jr., J.L. Carlson, M.J. Lynn, and P. Sternberg Jr. Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses Free Radic. Biol. Med. 33 2002 1290 1300
65. P.S. Samiec, C. Drews-Botsch, E.W. Flagg, J.C. Kurtz, P. Sternberg Jr., R.L. Reed, and D.P. Jones Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes Free Radic. Biol. Med. 24 1998 699 704
66. S. Ashfaq, J.L. Abramson, D.P. Jones, S.D. Rhodes, W.S. Weintraub, W.C. Hooper, V. Vaccarino, D.G. Harrison, and A.A. Quyyumi The relationship between plasma levels of oxidized and reduced thiols and early atherosclerosis in healthy adults J. Am. Coll. Cardiol. 47 2006 1005 1011
67. C.R. Jonas, A.B. Puckett, D.P. Jones, D.P. Griffith, E.E. Szeszycki, G.F. Bergman, C.E. Furr, C. Tyre, J.L. Carlson, J.R. Galloway, J.B. Blumberg, and T.R. Ziegler Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients Am. J. Clin. Nutr. 72 2000 181 189
68. R.A. Blanco, T.R. Ziegler, B.A. Carlson, P.-Y. Cheng, Y. Park, G.A. Cotsonis, C.J. Accardi, and D.P. Jones Diurnal variation in glutathione and cysteine redox states in human plasma Am. J. Clin. Nutr. 86 2007 1016 1023
69. P.R. Hamann, L.M. Hinman, I. Hollander, C.F. Beyer, D. Lindh, R. Holcomb, W. Hallett, H.-R. Tsou, J. Upeslacis, D. Shochat, A. Mountain, D.A. Flowers, and I. Bernstein Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia Bioconjug. Chem. 13 2001 47 58
70. P.R. Hamann, L.M. Hinman, C.F. Beyer, D. Lindh, J. Upeslacis, D.A. Flowers, and I. Bernstein An anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. Choice of linker Bioconjug. Chem. 13 2002 40 46
71. Y. Li, A. Nese, N.V. Lebedeva, T. Davis, K. Matyjaszewski, and S.S. Sheiko Molecular tensile machines: intrinsic acceleration of disulfide reduction by dithiothreitol J. Am. Chem. Soc. 133 2011 17479 17484
72. C. Wu, C. Belenda, J.-C. Leroux, and M.A. Gauthier Interplay of chemical microenvironment and redox environment on thiol-disulfide exchange kinetics Chem. Eur. J. 17 2011 10064 10070
73. S.J. Lee, M.S. Huh, S.Y. Lee, S. Min, S. Lee, H. Koo, J.-U. Chu, K.E. Lee, H. Jeon, Y. Choi, K. Choi, Y. Byun, S.Y. Jeong, K. Park, K. Kim, and I.C. Kwon Tumor-homing poly-siRNA/glycol chitosan self-cross-linked nanoparticles for systemic siRNA delivery in cancer treatment Angew. Chem. Int. Ed. 51 2012 7203 7207
74. X. Chen, Y. Bai, J.L. Zaro, and W.-C. Shen Design of an in vivo cleavable disulfide linker in recombinant fusion proteins Biotechnol. Tech. 49 2010 513 518
75. V. Torchilin Tumor delivery of macromolecular drugs based on the EPR effect Adv. Drug Deliv. Rev. 63 2011 131 135
76. L. Chaiswing, and T.D. Oberley Extracellular/microenvironmental redox state Antioxid. Redox Signal. 13 2010 449 465
77. P. Kuppusamy, H. Li, G. Ilangovan, A.J. Cardounel, J.L. Zweier, K. Yamada, M.C. Krishna, and J.B. Mitchell Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels Cancer Res. 62 2002 307 312
78. G.K. Balendiran, R. Dabur, and D. Fraser The role of glutathione in cancer Cell Biochem. Funct. 22 2004 343 352
79. J.M. Estrela, A. Ortega, and E. Obrador Glutathione in cancer biology and therapy Crit. Rev. Clin. Lab. Sci. 43 2006 143 181
80. G.I. Evan, and K.H. Vousden Proliferation, cell cycle and apoptosis in cancer Nature 411 2001 342 348
81. D.P. Jones Redox sensing: orthogonal control in cell cycle and apoptosis signalling J. Intern. Med. 268 2010 432 448
82. D.P. Jones Extracellular redox state: refining the definition of oxidative stress in aging Rejuvenation Res. 9 2006 169 181
83. C.R. Jonas, T.R. Ziegler, L.i.H Gu, and D.P. Jones Extracellular thiol/disulfide redox state affects proliferation rate in a human colon carcinoma (Caco2) cell line Free Radic. Biol. Med. 33 2002 1499 1506
84. L.E. Gerweck, and K. Seetharaman Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer Cancer Res. 56 1996 1194 1198
85. J.S. Fang, R.D. Gillies, and R.A. Gatenby Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression Semin. Cancer Biol. 18 2008 330 337
86. R.A. Gatenby, E.T. Gawlinski, A.F. Gmitro, B. Kaylor, and R.J. Gillies Acid-mediated tumor invasion: a multidisciplinary study Cancer Res. 66 2006 5216 5223
87. R.P. Szajewski, and G.M. Whitesides Rate constants and equilibrium constants for thiol-disulfide interchange reactions involving oxidized glutathione J. Am. Chem. Soc. 102 1980 2011 2025
88. H.J. Ryser, R. Mandel, and F. Ghani Cell surface sulfhydryls are required for the cytotoxicity of diphtheria toxin but not of ricin in chinese hamster ovary cells J. Biol. Chem. 266 1991 18439 18442
89. J. Wan, S. Persiani, and W.-C. Shen Transcellular processing of disulfide- and thioether-linked peroxidase-polylysine conjugates in cultured MDCK epithelial cells J. Cell. Physiol. 145 1990 9 15
90. R. Mandel, H.J. Ryser, F. Ghani, M. Wu, and D. Peak Inhibition of a reductive function of the plasma membrane by bacitracin and antibodies against protein disulfide-isomerase Proc. Natl. Acad. Sci. U. S. A. 90 1993 4112 4116
91. E. Feener, W. Shen, and H. Ryser Cleavage of disulfide bonds in endocytosed macromolecules. A processing not associated with lysosomes or endosomes J. Biol. Chem. 265 1990 18780 18785
92. S. Jiang, S.E. Moriarty-Craige, M. Orr, J. Cai, P. Sternberg, and D.P. Jones Oxidant-induced apoptosis in human retinal pigment epithelial cells: dependence on extracellular redox state Investig. Ophthalmol. Vis. Sci. 46 2005 1054 1061
93. Y.-M. Go, and D.P. Jones Intracellular proatherogenic events and cell adhesion modulated by extracellular thiol/disulfide redox state Circulation 111 2005 2973 2980
94. A.G. Torres, and M.J. Gait Exploiting cell surface thiols to enhance cellular uptake Trends Biotechnol. 30 2012 185 190
95. L. Brülisauer, G. Valentino, S. Morinaga, C. Kübra, J. Thostrup Bukrinski, M.A. Gauthier, and J.-C. Leroux Bio-reduction of redox-sensitive albumin conjugates in FcRn-expressing cells Angew. Chem. Int. Ed. 2014 10.1002/anie.201404238
96. A.H. Abou Ghalia, and I.M. Fouad Glutathione and its metabolizing enzymes in patients with different benign and malignant diseases Clin. Biochem. 33 2000 657 662
97. R.L. Pisoni, T.L. Acker, K.M. Lisowski, R.M. Lemons, and J.G. Thoene A cysteine-specific lysosomal transport system provides a major route for the delivery of thiol to human fibroblast lysosomes: Possible role in supporting lysosomal proteolysis J. Cell Biol. 110 1990 327 335
98. D. Gainey, S. Short, and K.L. McCoy Intracellular location of cysteine transport activity correlates with productive processing of antigen disulfide J. Cell. Physiol. 168 1996 248 254
99. U.T. Phan, B. Arunachalam, and P. Cresswell Gamma-interferon-inducible lysosomal thiol reductase (GILT). Maturation, activity, and mechanism of action J. Biol. Chem. 275 2000 25907 25914
100. K.T. Hastings, and P. Cresswell Disulfide reduction in the endocytic pathway: immunological functions of gamma-interferon-inducible lysosomal thiol reductase Antioxid. Redox Signal. 15 2011 657 668
101. S. Cerritelli, D. Velluto, and J.A. Hubbell PEG-SS-PPS: reduction-sensitive disulfide block copolymer vesicles for intracellular drug delivery Biomacromolecules 8 2007 1966 1972
102. D. Shah, and W.-C. Shen Transcellular delivery of an insulin-transferrin conjugate in enterocyte-like Caco-2 cells J. Pharm. Sci. 85 1996 1306 1311
103. F.Q. Schafer, and G.R. Buettner Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple Free Radic. Biol. Med. 30 2001 1191 1212
104. R.E. Hansen, D. Roth, and J.R. Winther Quantifying the global cellular thiol-disulfide status Proc. Natl. Acad. Sci. U. S. A. 106 2009 422 427
105. D.J. Phillips, and M.I. Gibson Redox-sensitive materials for drug delivery: targeting the correct intracellular environment, tuning release rates and appropriate predictive systems Antioxid. Redox Signal. 2013 10.1089/ars.2013.5728
106. C. Wu, J.-C. Leroux, and M.A. Gauthier Twin disulfides for orthogonal disulfide pairing and the directed folding of multicyclic peptides Nat. Chem. 4 2012 1044 1049